We describe a new chiral tubule-forming lipid in which the C-O-P headgroup/glycerol backbone linkage of the archetypal tubule-forming phospholipid, 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphocholine, DC(8,9)PC, is replaced by a C-C-P linkage. Tubule formation from this phosphonate analogue occurs under the same mild conditions as with DC(8,9)PC and produces identical yields, but the phosphonate tubules have cylindrical diameters twice that of DC(8,9)PC tubules. Small-angle X-ray scattering, atomicforce, and optical microscopy reveal the new tubules to consist of fewer coaxially nested cylindrical lamellae than DC(8,9)PC tubules; accordingly, the phosphonate tubules are more fragile. In addition, a small portion of the phosphonate precipitate is in the form of stable open helices, and enantiomerically pure preparations of the new molecule contain significant numbers of helices possessing the unexpected sense of handedness.
We describe a new chiral tubule-forming lipid in which the C-O-P phosphoryl linkage of the archetypal tubule-forming molecule, 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphocholine, "DC(8,9)PC", is replaced by a C-P linkage. Tubule formation with this phosphonate analogue proceeds under the same mild conditions as with DC(8,9)PC and produces similar yields, but synchrotron small-angle X-ray scattering, atomic force microscopy, and optical microscopy show the new tubules to have diameters 1.94 times as great, to be significantly shorter, and to be thinner-walled. A significant portion of the enantiomerically pure chiral phosphonate precipitate is in the form of stable open helices, and these helices are divided almost evenly between left- and right-handed members.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.